Last reviewed · How we verify
NCT04494035: AVATR
AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System
NA trial testing CAPERE Thrombectomy System in Arteriovenous Graft Thrombosis in 7 participants. Terminated before completion.
23 October 2020
Quick facts
| Lead sponsor | Medtronic Endovascular |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 7 |
| Start date | 14 January 2020 |
| Primary completion | 23 October 2020 |
| Estimated completion | 23 October 2020 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- CAPERE Thrombectomy System
Conditions studied
- Arteriovenous Graft Thrombosis — all drugs for Arteriovenous Graft Thrombosis →
Sponsor
Medtronic Endovascular — full company profile →
Who can join
18 and older, any sex, with Arteriovenous Graft Thrombosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective, single-arm, non-blinded study, intending to treat and collect and evaluate data in up to ten (10) human subjects who are currently being treated with hemodialysis and who present with acute thrombosis in their arteriovenous (AV) grafts, treated with the CAPERE® Thrombectomy System.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04494035
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CAPERE Thrombectomy System
Trials testing the same drug.
- NCT03869645 — CAPERE Thrombectomy System Post-Market Clinical Follow Up Study · terminated
Other Medtronic Endovascular trials
Trials by the same sponsor.
- NCT04484220 — Ellipsys Vascular Access System Post Market Surveillance (PS) Study · NA · completed
- NCT03820947 — VenaSeal Spectrum: Global Post-Market Randomized Controlled Trial · NA · terminated
- NCT04120610 — FlowMet-R Blood Flow Measurement for the Diagnosis of Peripheral Artery Disease and Critical Limb Ischemia · terminated
- NCT03869645 — CAPERE Thrombectomy System Post-Market Clinical Follow Up Study · terminated
- NCT03038438 — ABRE Clinical Study of the Abre Venous Self-expanding Stent System · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04494035 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medtronic Endovascular
- Last refreshed: 13 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04494035.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing